CarrierScreening Market, by Test Type (Expanded Carrier Screening and TargetedDisease Carrier Screening), by Disease Type (Cystic Fibrosis, Sickle CellDisease, Spinal Muscular Atrophy, Fragile X Syndrome, Thalassemia, and Others),by End User (Hospitals, Reference Laboratories, and Others), and by Region(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
Genetic disorders are diseasescaused due to change in the normal DNA sequence. These changes are known asmutations, which can occur in one or multiple genes. A person carries genes inpair, one from each parent. The person carrying the mutated gene for thegenetic disorder is known as the carrier. If both the parents are carriers ofthe gene associated with the genetic disorder, then there is 25% chance thatthe child will be born with the disorder. If only one parent is the carrier ofthe mutated gene then there is 50% chance that the child will be carrying themutated gene.
Carrier screening is a type oftest which helps in determining the risk of having a child with a geneticdisease. Carrier screening determines whether a healthy person carries therecessive gene of genetic diseases such as cystic fibrosis, sickle celldisease, and others.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/3500
Global Carrier Screening Market –Dynamics
Rising mergers, agreements, andacquisitions by market players are expected to drive the global carrierscreening market over the forecast period. For instance, in July 2017, Counsyl,Inc., entered into an expanded agreement with Angsana Molecular &Diagnostics Laboratory, a multinational laboratory services company, tocommercialize expanded carrier screening (ECS) test in Hong Kong. Furthermore,in July 2018, Counsyl, Inc. was acquired by Myriad Genetics, Inc. Theacquisition is expected to strengthen the genetic tests portfolio of MyriadGenetics, Inc.
Moreover, various launches andapprovals of new carrier screening tests are likely to propel growth of thecarrier screening market during the forecast period. For instance, in June2018, Invitae Corporation, announced the launch of Invitae Carrier Screen,which is a test designed for enhanced risk assessment to determine thepossibility of the child having a genetic disorder.
Global Carrier Screening Market –Regional Insights
North America accounted for thelargest market share in 2018, owing to product approvals and launches of newcarrier screening tests in the region. For instance, in October 2019, Sema4,announced the launch of Expanded Carrier Screen, a test which determines therisk of an inherited genetic disorder in the child.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/carrier-screening-market-3500
Europe is also witnessinglucrative growth in the carrier screening market owing to launches andapprovals of new screening tests in the region. For instance, in June 2019,QIAGEN, a German provider of sample and assay technologies for moleculardiagnostics, launched QIAseq Expanded Carrier Screening Panel. The QIAseqprovides information about the targets and genes that are responsible for 200 diseaseindications.
Global Carrier Screening Market –Competitive landscape
Key players operating in theglobal carrier screening market include Invitae Corporation, Thermo FisherScientific, Quest Diagnostics, Sema4, Myriad Genetics, Inc., Illumina, Inc.,Fulgent Genetics, Gene by Gene, CENTOGENE N.V., QIAGEN, Eurofins Scientific,Luminex Corporation, Medgenome, and others.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/3500
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offering action-readysyndicated research reports, custom market analysis, consulting services, andcompetitive analysis through various recommendations related to emerging markettrends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
